Cargando…
Successful Treatment of Oral Crohn’s Disease by Ustekinumab
We report on a Crohn’s disease patient with severe dysphagia and malnutrion due to Crohn’s-related cheilitis and tonsillitis that was refractory to steroids, anti-TNF, and anti-integrin therapy but was successfully treated with ustekinumab.
Autores principales: | Jukema, Jelmer B, Brandse, Johannan F, de Boer, Nanne K H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186322/ https://www.ncbi.nlm.nih.gov/pubmed/31907551 http://dx.doi.org/10.1093/ibd/izz321 |
Ejemplares similares
-
Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016) -
Successful Drug Desensitization to Ustekinumab in a Patient with Crohn's Disease
por: Cohen, Barrie, et al.
Publicado: (2021) -
Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab
por: Agusti-Mejias, Anna, et al.
Publicado: (2013) -
Clinical utility of ustekinumab in Crohn’s disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018) -
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
por: Biemans, Vince B C, et al.
Publicado: (2020)